Indian pharmaceutical giant Wockhardt is currently in merger talks. The company, known for its diverse selection of generic and branded pharmaceuticals, has been facing headwinds in recent quarters. Sources close to the transaction suggest that Wockhardt is {attracting interest from|receiving bids from both domestic and international firms. A final